Literature DB >> 35380470

Prime time for doxorubicin-induced cardiotoxicity genetic testing.

Tarek Magdy1,2, Paul W Burridge1,2.   

Abstract

Entities:  

Keywords:  cardiotoxicity; chemotherapy; clinical translation; human-induced pluripotent stem cells; pharmacogenomics

Mesh：

Substances：

Year:  2022        PMID： 35380470      PMCID： PMC9006338          DOI： 10.2217/pgs-2022-0032

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  24 in total

1.  Phase II and phase III failures: 2013-2015.

Authors:  Richard K Harrison
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

2.  Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giulia Bacchiani; Ines Tedeschi; Carlo A Meroni; Fabrizio Veglia; Maurizio Civelli; Giuseppina Lamantia; Nicola Colombo; Giuseppe Curigliano; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2015-05-06       Impact factor: 29.690

3.  Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells.

Authors:  Faye M Drawnel; Stefano Boccardo; Michael Prummer; Frédéric Delobel; Alexandra Graff; Michael Weber; Régine Gérard; Laura Badi; Tony Kam-Thong; Lei Bu; Xin Jiang; Jean-Christophe Hoflack; Anna Kiialainen; Elena Jeworutzki; Natsuyo Aoyama; Coby Carlson; Mark Burcin; Gianni Gromo; Markus Boehringer; Henning Stahlberg; Benjamin J Hall; Maria Chiara Magnone; Kyle Kolaja; Kenneth R Chien; Jacques Bailly; Roberto Iacone
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

4.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

5.  Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.

Authors:  Xonia Carvajal-Vergara; Ana Sevilla; Sunita L D'Souza; Yen-Sin Ang; Christoph Schaniel; Dung-Fang Lee; Lei Yang; Aaron D Kaplan; Eric D Adler; Roye Rozov; Yongchao Ge; Ninette Cohen; Lisa J Edelmann; Betty Chang; Avinash Waghray; Jie Su; Sherly Pardo; Klaske D Lichtenbelt; Marco Tartaglia; Bruce D Gelb; Ihor R Lemischka
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

8.  Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.

Authors:  Masayuki Yazawa; Brian Hsueh; Xiaolin Jia; Anca M Pasca; Jonathan A Bernstein; Joachim Hallmayer; Ricardo E Dolmetsch
Journal:  Nature       Date:  2011-02-09       Impact factor: 49.962

Review 9.  From iPSC towards cardiac tissue-a road under construction.

Authors:  Stefan Peischard; Ilaria Piccini; Nathalie Strutz-Seebohm; Boris Greber; Guiscard Seebohm
Journal:  Pflugers Arch       Date:  2017-06-01       Impact factor: 3.657

10.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.

Authors:  Changsung Kim; Johnson Wong; Jianyan Wen; Shirong Wang; Cheng Wang; Sean Spiering; Natalia G Kan; Sonia Forcales; Pier Lorenzo Puri; Teresa C Leone; Joseph E Marine; Hugh Calkins; Daniel P Kelly; Daniel P Judge; Huei-Sheng Vincent Chen
Journal:  Nature       Date:  2013-01-27       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.